Clinical Trial

Study on Effectiveness and Safety of LBBaP With Solia S and Selectra 3D Developed by BIOTRONIK

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 26, 2024 (before its estimated April 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is aimed to assess the effectiveness and safety of LBBaP with Solia S and Selectra 3D in the Chinese population by analyzing the operation success rate and the system stability during follow-up visits.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-03-20.
Status change: Not Yet Recruiting → Recruiting 2024-08-21
Trial Details
NCT Number NCT05793502
Lead Sponsor Chinese Academy of Medical Sciences, Fuwai Hospital
Conditions Consented to Participate in the Trial and Signed an ICF, Patients With an Indication for PM Implantation or CRTP
Enrollment 1,000 participants
Start Date 2023-07-04
Primary Completion 2025-04-20 (estimated)
Study Completion 2025-04-20 (estimated)
Updated on ClinicalTrials.gov 2024-08-26